Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study
Background: Elevated total homocysteine (tHcy) levels may be caused by vitamin B12 deficiency and are linked to Alzheimers disease (AD) in some studies, although the evidence is mixed. Another marker of vitamin B12 deficiency, holo‐transcobalamin (holo‐TC), has not been studied in a prospective set...
Saved in:
| Published in | European journal of neurology Vol. 16; no. 7; pp. 808 - 813 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford, UK
Blackwell Publishing Ltd
01.07.2009
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Background: Elevated total homocysteine (tHcy) levels may be caused by vitamin B12 deficiency and are linked to Alzheimers disease (AD) in some studies, although the evidence is mixed. Another marker of vitamin B12 deficiency, holo‐transcobalamin (holo‐TC), has not been studied in a prospective setting.
Objective: To investigate the association between tHcy and holo‐TC and the subsequent development of dementia and AD in a prospective study.
Methods: A sub‐sample of 228 non‐demented subjects was taken from the Kungsholmen Project, a population‐based longitudinal study amongst persons 75+ years. tHcy and holo‐TC were analysed at baseline.
Results: Increasing tHcy levels were related to an increased risk of dementia (n = 83) and AD (n = 61) after a mean follow‐up time of 6.7 years. Persons with high tHcy (the fourth quartile) had more than twice as high a risk of developing AD than persons with low tHcy, even after adjusting for confounding or mediating factors. The third quartile of holo‐TC was associated with a reduced risk of AD, after adjusting for Hcy and other confounders.
Conclusions: These results suggest that Hcy is involved in the development of dementia and AD. The role of holo‐TC was less clear and this marker needs to be studied further. |
|---|---|
| AbstractList | Background: Elevated total homocysteine (tHcy) levels may be caused by vitamin B12 deficiency and are linked to Alzheimers disease (AD) in some studies, although the evidence is mixed. Another marker of vitamin B12 deficiency, holo‐transcobalamin (holo‐TC), has not been studied in a prospective setting.
Objective: To investigate the association between tHcy and holo‐TC and the subsequent development of dementia and AD in a prospective study.
Methods: A sub‐sample of 228 non‐demented subjects was taken from the Kungsholmen Project, a population‐based longitudinal study amongst persons 75+ years. tHcy and holo‐TC were analysed at baseline.
Results: Increasing tHcy levels were related to an increased risk of dementia (n = 83) and AD (n = 61) after a mean follow‐up time of 6.7 years. Persons with high tHcy (the fourth quartile) had more than twice as high a risk of developing AD than persons with low tHcy, even after adjusting for confounding or mediating factors. The third quartile of holo‐TC was associated with a reduced risk of AD, after adjusting for Hcy and other confounders.
Conclusions: These results suggest that Hcy is involved in the development of dementia and AD. The role of holo‐TC was less clear and this marker needs to be studied further. BACKGROUND: Elevated total homocysteine (tHcy) levels may be caused by vitamin B12 deficiency and are linked to Alzheimers disease (AD) in some studies, although the evidence is mixed. Another marker of vitamin B12 deficiency, holo-transcobalamin (holo-TC), has not been studied in a prospective setting. OBJECTIVE: To investigate the association between tHcy and holo-TC and the subsequent development of dementia and AD in a prospective study. METHODS: A sub-sample of 228 non-demented subjects was taken from the Kungsholmen Project, a population-based longitudinal study amongst persons 75+ years. tHcy and holo-TC were analysed at baseline. RESULTS: Increasing tHcy levels were related to an increased risk of dementia (n = 83) and AD (n = 61) after a mean follow-up time of 6.7 years. Persons with high tHcy (the fourth quartile) had more than twice as high a risk of developing AD than persons with low tHcy, even after adjusting for confounding or mediating factors. The third quartile of holo-TC was associated with a reduced risk of AD, after adjusting for Hcy and other confounders. CONCLUSIONS: These results suggest that Hcy is involved in the development of dementia and AD. The role of holo-TC was less clear and this marker needs to be studied further. Elevated total homocysteine (tHcy) levels may be caused by vitamin B12 deficiency and are linked to Alzheimers disease (AD) in some studies, although the evidence is mixed. Another marker of vitamin B12 deficiency, holo-transcobalamin (holo-TC), has not been studied in a prospective setting. To investigate the association between tHcy and holo-TC and the subsequent development of dementia and AD in a prospective study. A sub-sample of 228 non-demented subjects was taken from the Kungsholmen Project, a population-based longitudinal study amongst persons 75+ years. tHcy and holo-TC were analysed at baseline. Increasing tHcy levels were related to an increased risk of dementia (n = 83) and AD (n = 61) after a mean follow-up time of 6.7 years. Persons with high tHcy (the fourth quartile) had more than twice as high a risk of developing AD than persons with low tHcy, even after adjusting for confounding or mediating factors. The third quartile of holo-TC was associated with a reduced risk of AD, after adjusting for Hcy and other confounders. These results suggest that Hcy is involved in the development of dementia and AD. The role of holo-TC was less clear and this marker needs to be studied further. BACKGROUNDElevated total homocysteine (tHcy) levels may be caused by vitamin B12 deficiency and are linked to Alzheimers disease (AD) in some studies, although the evidence is mixed. Another marker of vitamin B12 deficiency, holo-transcobalamin (holo-TC), has not been studied in a prospective setting.OBJECTIVETo investigate the association between tHcy and holo-TC and the subsequent development of dementia and AD in a prospective study.METHODSA sub-sample of 228 non-demented subjects was taken from the Kungsholmen Project, a population-based longitudinal study amongst persons 75+ years. tHcy and holo-TC were analysed at baseline.RESULTSIncreasing tHcy levels were related to an increased risk of dementia (n = 83) and AD (n = 61) after a mean follow-up time of 6.7 years. Persons with high tHcy (the fourth quartile) had more than twice as high a risk of developing AD than persons with low tHcy, even after adjusting for confounding or mediating factors. The third quartile of holo-TC was associated with a reduced risk of AD, after adjusting for Hcy and other confounders.CONCLUSIONSThese results suggest that Hcy is involved in the development of dementia and AD. The role of holo-TC was less clear and this marker needs to be studied further. |
| Author | Viitanen, M. Kivipelto, M. Hultdin, J. Bäckman, L. Fratiglioni, L. Lökk, J. Annerbo, S. |
| Author_xml | – sequence: 1 givenname: M. surname: Kivipelto fullname: Kivipelto, M. organization: Aging Research Center, Karolinska Institutet and Stockholm Gerontology Research Center, Stockholm, Sweden – sequence: 2 givenname: S. surname: Annerbo fullname: Annerbo, S. organization: Department of Neurobiology, Caring Sciences and Society, Karolinska Institutet, Sweden – sequence: 3 givenname: J. surname: Hultdin fullname: Hultdin, J. organization: Department of Medical Biosciences, Clinical Chemistry, Umeå University Hospital, Umeå, Sweden – sequence: 4 givenname: L. surname: Bäckman fullname: Bäckman, L. organization: Aging Research Center, Karolinska Institutet and Stockholm Gerontology Research Center, Stockholm, Sweden – sequence: 5 givenname: M. surname: Viitanen fullname: Viitanen, M. organization: Department of Geriatrics, Karolinska University Hospital, Huddinge, Sweden – sequence: 6 givenname: L. surname: Fratiglioni fullname: Fratiglioni, L. organization: Aging Research Center, Karolinska Institutet and Stockholm Gerontology Research Center, Stockholm, Sweden – sequence: 7 givenname: J. surname: Lökk fullname: Lökk, J. organization: Department of Geriatrics, Karolinska University Hospital, Huddinge, Sweden |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19453410$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-30364$$DView record from Swedish Publication Index http://kipublications.ki.se/Default.aspx?queryparsed=id:118856746$$DView record from Swedish Publication Index |
| BookMark | eNqFUl1v0zAUtdAQ-4C_gPzEE-nsOP4IEg9dVzakaUh8jEfLTm6o2yQuccJafv2ctpQnhKUrH917ztWRzj1HJ61vASFMyYTGd7mc0EyohDJGJykh-YSkPCeTzTN0dhycRMw4TTgl9BSdh7AkhKQyJS_QKc0zzjJKzpC79Y0vtqEH1wI2bYkXvvZJ35k2FN6a2jSu3fX7BeDOhRX2FS6hgbZ3ZjeY1r8X4BroAi5dABPgHTZ43fmwhqJ3vwCHfii3L9HzytQBXh3-C_Ttw_zr7Da5-3TzcTa9SwqeEZIYy7jilFqVFUJaK4S1zMosFZYpZSsmc8KKyggqqlLSKqNQpaUCTpgiouLsAuX7veER1oPV6841pttqb1zEvtSH_sqNpQNoSpXiQmYiat_-U3vtHqbadz_00AyaESaySH-zp8e9PwcIvW5cKKCuTQt-CFpIziRl6X-JMUPBqRoNvD4QB9tAeTTwJ7BIeL8nPLoatn_nRI-HoZd6zF-P-Y9Lc707DL3R8_v5iKI-2etdjHxz1JtuFd0yyfX3-xs9-3L98JkIqa_YEwWjvf8 |
| CitedBy_id | crossref_primary_10_1159_000363054 crossref_primary_10_1007_s00702_010_0383_x crossref_primary_10_1007_s00702_012_0822_y crossref_primary_10_1016_j_nut_2009_11_009 crossref_primary_10_1186_s13104_015_1744_1 crossref_primary_10_1515_CCLM_2011_084 crossref_primary_10_1177_00045632211003605 crossref_primary_10_1212_WNL_0b013e3181f88162 crossref_primary_10_2174_1573405618666220516113758 crossref_primary_10_3945_an_112_002535 crossref_primary_10_3390_reactions5010002 crossref_primary_10_1136_jnnp_2019_322366 crossref_primary_10_1017_S000711451100674X crossref_primary_10_1111_j_1753_4887_2010_00353_x crossref_primary_10_1212_WNL_0b013e3181f8836f crossref_primary_10_3390_biom10020219 crossref_primary_10_36384_01232576_210 crossref_primary_10_1016_j_nutres_2012_09_005 crossref_primary_10_1016_j_nutres_2016_03_010 crossref_primary_10_1016_j_gmhc_2013_04_007 crossref_primary_10_1016_j_arr_2019_02_006 crossref_primary_10_1016_j_clnu_2021_05_034 crossref_primary_10_1016_j_biopha_2016_11_142 crossref_primary_10_1017_S0007114512004175 crossref_primary_10_3233_JAD_150651 crossref_primary_10_1093_epirev_mxs003 crossref_primary_10_19261_cjm_2023_1087 crossref_primary_10_1002_gps_2122 crossref_primary_10_3945_ajcn_113_076349 crossref_primary_10_1002_iub_2507 crossref_primary_10_1080_13607863_2011_583632 crossref_primary_10_1097_MCO_0b013e328333d157 crossref_primary_10_1111_j_1468_1331_2010_03248_x crossref_primary_10_1007_s10389_018_0996_3 crossref_primary_10_1016_j_jalz_2010_08_234 crossref_primary_10_1017_S1041610213001294 crossref_primary_10_1080_05704928_2016_1229325 crossref_primary_10_1111_j_1365_2796_2011_02484_x crossref_primary_10_19261_cjm_2016_11_1__01 crossref_primary_10_3174_ajnr_A3785 crossref_primary_10_3109_13813455_2010_512042 crossref_primary_10_3390_nu11010019 |
| ContentType | Journal Article |
| Copyright | 2009 The Author(s). Journal compilation © 2009 EFNS |
| Copyright_xml | – notice: 2009 The Author(s). Journal compilation © 2009 EFNS |
| DBID | BSCLL CGR CUY CVF ECM EIF NPM 7TK 7X8 ADTPV AOWAS D93 |
| DOI | 10.1111/j.1468-1331.2009.02590.x |
| DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts MEDLINE - Academic SwePub SwePub Articles SWEPUB Umeå universitet |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Neurosciences Abstracts MEDLINE - Academic |
| DatabaseTitleList | Neurosciences Abstracts MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1468-1331 1471-0552 |
| EndPage | 813 |
| ExternalDocumentID | oai_prod_swepub_kib_ki_se_118856746 oai_DiVA_org_umu_30364 19453410 ENE2590 ark_67375_WNG_CSDVR067_B |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 169 1OB 1OC 29G 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAVGM AAXRX AAZKR ABCQN ABCUV ABEML ABHUG ABIVO ABJNI ABPTK ABPVW ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFGKR AFPWT AFRAH AFVGU AFZJQ AGJLS AHMBA AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN ESX EX3 F00 F5P FEDTE FUBAC FYBCS G-S G.N GODZA H.X HF~ HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIG RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR XG1 YFH ZA5 ZZTAW ~IA ~WT 24P 7X7 8FI 8FJ ABUWG ADPDF AFKRA BENPR CCPQU FYUFA HMCUK OIG OVEED RPM UKHRP CGR CUY CVF ECM EIF NPM 7TK 7X8 ADTPV AOWAS D93 |
| ID | FETCH-LOGICAL-c5400-ab358511b84c67bb66bb3b7426b388bf37903cfa616fd71f41ef2d8e503806f53 |
| IEDL.DBID | DR2 |
| ISSN | 1351-5101 1468-1331 |
| IngestDate | Wed Oct 23 03:54:36 EDT 2024 Sat Aug 24 00:02:31 EDT 2024 Fri Aug 16 06:23:40 EDT 2024 Sat Aug 17 03:50:06 EDT 2024 Sat Sep 28 07:46:34 EDT 2024 Sat Aug 24 00:55:16 EDT 2024 Wed Jan 17 05:00:54 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5400-ab358511b84c67bb66bb3b7426b388bf37903cfa616fd71f41ef2d8e503806f53 |
| Notes | ArticleID:ENE2590 istex:2D52C6524970164B859A4C159F82DD59E2DD50B2 ark:/67375/WNG-CSDVR067-B ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 19453410 |
| PQID | 20065186 |
| PQPubID | 23462 |
| PageCount | 6 |
| ParticipantIDs | swepub_primary_oai_prod_swepub_kib_ki_se_118856746 swepub_primary_oai_DiVA_org_umu_30364 proquest_miscellaneous_67537132 proquest_miscellaneous_20065186 pubmed_primary_19453410 wiley_primary_10_1111_j_1468_1331_2009_02590_x_ENE2590 istex_primary_ark_67375_WNG_CSDVR067_B |
| PublicationCentury | 2000 |
| PublicationDate | July 2009 |
| PublicationDateYYYYMMDD | 2009-07-01 |
| PublicationDate_xml | – month: 07 year: 2009 text: July 2009 |
| PublicationDecade | 2000 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK – name: England |
| PublicationTitle | European journal of neurology |
| PublicationTitleAlternate | Eur J Neurol |
| PublicationYear | 2009 |
| Publisher | Blackwell Publishing Ltd |
| Publisher_xml | – name: Blackwell Publishing Ltd |
| References | Basun H, Fratiglioni L, Winblad B. Cobalamin levels are not reduced in Alzheimer′s disease: results from a population-based study. J Am Geriatr Soc 1994; 42: 132-136. Luchsinger JA, Tang MX, Miller J, Green R, Mayeux R. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol 2007; 64: 86-92. Mizrahi EH, Bowirrat A, Jacobsen DW, et al. Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs. J Neurol Sci 2004; 227: 109-113. Kim J-M, Stewart R, Kim S-W, et al. Changes in folate, vitamin B12 and homocysteine associated with incident dementia. J Neurol Neurosurg Psychiatry 2008; 79: 864-868. Björkegren K, Svärdsudd K. Serum cobalamin, folate, methylmalonic acid and total homocysteine as vitamin B12 and folate tissue deficiency markers amongst elderly Swedes - a population-based study. J Intern Med 2001; 249: 423-432. Wang HX, Wahlin Å, Basun H, Fastborn J, Winblad B, Fratiglioni L. Vitamin B12 and folat in relation to the development of Alzheimer′s disease. Neurology 2001; 56: 1188-1194. Schatz RA, Wilens TE, Sellinger OZ. Decreased in vivo protein and phospholipids methylation after in vivo elevation of brain S-adenosyl-1-homocysteine. Biochem Biophys Res Commun 1981; 98: 1097-10107. Schatz RA, Wilens TE, Sellinger OZ. Decreased transmethylation of biogenetic amines after in vivo elevation of brain S-adenosyl-1-homocysteine. J Neurochem 1981a; 36: 1739-1748. Hvas A-M, Juul S, Lauritzen L, Nexø E, Ellegard J. No effect of vitamin B-12 treatment on cognitive function and depression: a randomized placebo controlled study. J Affect Disord 2004; 81: 269-273. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer′s disease. Arch Neurol 1998; 55: 1449-1455. Miller JW, Green R, Mungas DM, Reed BR, Jagust WJ. Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology 2002; 58: 1471-1475. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised (DSM-III-R). Washington, DC: American Psychiatric Association, 1987; pp. 97-163. Smith AD. The worldwide challenge of the dementias: a role for B vitamins and homocysteine? Food and Nutrition Bulletin 2008; 29: S143-S172. Porter RH, Roberts PJ. Glutamate metabotropic receptor activation in neonatal rat cerebral cortex by sulphur-containing excitatory amino acids. Neurosci Lett 1993; 154: 78-80. Zetterberg M, Nexø E, Regland B, et al. The transcobalamin (TC) codon 259 genetic polymorphism influences holo-TC concentration in cerebrospinal fluid from patients with Alzheimer disease. Clin Chem 2003; 49: 1195-1198. Wang HX, Karp A, Winblad B, Fratiglioni L. Late-life engagement in social and leisure activities is associated with decreased risk of dementia: a longitudinal study from the Kungsholmen project. Am J Epidemiol 2002; 155: 1081-1087. Schneede J, Refsum H, Ueland PM. Biological and Environmental Determinants of Plasma Homocysteine. Semin Thromb Hemost 2000; 26: 263-279. Nilsson K, Gustafson L, Hultberg B. Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 2001; 16: 609-614. Clarke R, Grimley Evans J, Schneede J, et al. Vitamin B12 and folate deficiency in later life. Age Ageing 2004; 33: 34-41. Refsum H, Smith AD. Low vitamin B-12 status in confirmed Alzheimer′s disease as revealed by serum holo-Transcobalamin. J Neurol Neurosurg Psychiatry 2003; 74: 959-961. Durga J, Van Boxtel MPJ, Schouten EG, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomized, double blind, controlled trial. Lancet 2007; 369: 208-216. Quadri P, Fragiacomo C, Pezzati R, et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 2004; 80: 114-122. Wahlin Å, Hill RD, Winblad B, Bäckman L. Effects of serum vitamin B12 and folate status on episodic memory performance in very old age: a population based study. Psychol Aging 1996; 11: 487-496. Bønaa KH, Njølstad A, Ueland PM, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006; 354: 1578-1588. Hvas AM, Nexø E. Holotranscobalamin - a first choice assay for diagnosing early vitamin B12 deficiency? J Intern Med 2005; 257: 289-298. Kivipelto M, Helkala EL, Hänninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001; 56: 1683-1689. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. Moderately elevated plasma homocysteine, methylentetrahydrofolate reductase genotype, and risk for stroke, vascular dementia and Alzheimer′s disease in Northern Ireland. Stroke 2002; 33: 2351-2356. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 339-359. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476-483. Li Z, Sun L, Zhang H, et al. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylentetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke. A Multicenter Case-Control Study in China. Stroke 2003; 34: 2085-2090. Teunisse S, Bollen A, Van Gool WA, Walstra GJM. Dementia and subnormal levels of vitamin B12: effects of replacement therapy on dementia. J Neurol 1996; 243: 522-529. Luchsinger JA, Tang MX, Shea S, Miller J, Green R, Mayeux R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004; 62: 1972-1976. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. J Am Med Assoc 2004; 291: 565-575. Smirnova T, Stinnakre J, Mallet J. Characterization of presynaptic glutamate receptor. Science 1993; 262: 430-433. Haan MN, Miller JW, Aiello AE, et al. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment; results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2007; 85: 511-517. Fratiglioni L, Viitanen M, Bäckman L, Sandman PO, Winblad B. Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology 1992b; 11(Suppl. 1): 29-36. McCaddon A, Davis G, Hudson P, Tandy S, Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998; 13: 235-239. Schmand B, Smit J, Lindeboom J, et al. Low education is a genuine risk factor for accelerated memory decline and dementia. JCE 1997; 50: 1025-1033. Chambers JC, Obeid OA, Refsum H, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000; 355: 523-527. Ravaglia G, Forti P, Maioli F, et al. Homocysteine and folate as risk factors for dementia and Alzheimer's disease. Am J Clin Nutr 2005; 82: 636-643. 2002; 58 2004; 62 2004; 81 2007; 369 2000; 355 2000; 26 2005; 257 2002; 155 2002; 33 1991; 82 1993; 262 2008; 79 1996; 243 2005; 82 2004; 227 2003; 74 2006; 354 2001; 249 1996; 11 1994; 42 2003; 34 1981a; 36 2004; 33 1997; 50 2004; 291 2008; 29 1987 2002; 346 2003; 49 1992b; 11 2001; 16 2007; 85 2007; 64 2001; 56 2004; 80 1993; 154 1981; 98 1998; 55 1998; 13 |
| References_xml | – volume: 58 start-page: 1471 year: 2002 end-page: 1475 article-title: Homocysteine, vitamin B6, and vascular disease in AD patients publication-title: Neurology – volume: 82 start-page: 636 year: 2005 end-page: 643 article-title: Homocysteine and folate as risk factors for dementia and Alzheimer's disease publication-title: Am J Clin Nutr – volume: 82 start-page: 339 year: 1991 end-page: 359 article-title: Neuropathological stageing of Alzheimer‐related changes publication-title: Acta Neuropathol – start-page: 97 year: 1987 end-page: 163 – volume: 98 start-page: 1097 year: 1981 end-page: 10107 article-title: Decreased in vivo protein and phospholipids methylation after in vivo elevation of brain S‐adenosyl‐1‐homocysteine publication-title: Biochem Biophys Res Commun – volume: 62 start-page: 1972 year: 2004 end-page: 1976 article-title: Plasma homocysteine levels and risk of Alzheimer disease publication-title: Neurology – volume: 34 start-page: 2085 year: 2003 end-page: 2090 article-title: Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylentetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke. A Multicenter Case‐Control Study in China publication-title: Stroke – volume: 262 start-page: 430 year: 1993 end-page: 433 article-title: Characterization of presynaptic glutamate receptor publication-title: Science – volume: 33 start-page: 2351 year: 2002 end-page: 2356 article-title: Moderately elevated plasma homocysteine, methylentetrahydrofolate reductase genotype, and risk for stroke, vascular dementia and Alzheimer′s disease in Northern Ireland publication-title: Stroke – volume: 227 start-page: 109 year: 2004 end-page: 113 article-title: Plasma homocysteine, vitamin B12 and folate in Alzheimer’s patients and healthy Arabs publication-title: J Neurol Sci – volume: 155 start-page: 1081 year: 2002 end-page: 1087 article-title: Late‐life engagement in social and leisure activities is associated with decreased risk of dementia: a longitudinal study from the Kungsholmen project publication-title: Am J Epidemiol – volume: 42 start-page: 132 year: 1994 end-page: 136 article-title: Cobalamin levels are not reduced in Alzheimer′s disease: results from a population‐based study publication-title: J Am Geriatr Soc – volume: 346 start-page: 476 year: 2002 end-page: 483 article-title: Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease publication-title: N Engl J Med – volume: 81 start-page: 269 year: 2004 end-page: 273 article-title: No effect of vitamin B‐12 treatment on cognitive function and depression: a randomized placebo controlled study publication-title: J Affect Disord – volume: 55 start-page: 1449 year: 1998 end-page: 1455 article-title: Folate, vitamin B , and serum total homocysteine levels in confirmed Alzheimer′s disease publication-title: Arch Neurol – volume: 369 start-page: 208 year: 2007 end-page: 216 article-title: Effect of 3‐year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomized, double blind, controlled trial publication-title: Lancet – volume: 16 start-page: 609 year: 2001 end-page: 614 article-title: Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine publication-title: Int J Geriatr Psychiatry – volume: 80 start-page: 114 year: 2004 end-page: 122 article-title: Homocysteine, folate, and vitamin B‐12 in mild cognitive impairment, Alzheimer disease, and vascular dementia publication-title: Am J Clin Nutr – volume: 243 start-page: 522 year: 1996 end-page: 529 article-title: Dementia and subnormal levels of vitamin B : effects of replacement therapy on dementia publication-title: J Neurol – volume: 26 start-page: 263 year: 2000 end-page: 279 article-title: Biological and Environmental Determinants of Plasma Homocysteine publication-title: Semin Thromb Hemost – volume: 13 start-page: 235 year: 1998 end-page: 239 article-title: Total serum homocysteine in senile dementia of Alzheimer type publication-title: Int J Geriatr Psychiatry – volume: 79 start-page: 864 year: 2008 end-page: 868 article-title: Changes in folate, vitamin B12 and homocysteine associated with incident dementia publication-title: J Neurol Neurosurg Psychiatry – volume: 291 start-page: 565 year: 2004 end-page: 575 article-title: Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial publication-title: J Am Med Assoc – volume: 49 start-page: 1195 year: 2003 end-page: 1198 article-title: The transcobalamin (TC) codon 259 genetic polymorphism influences holo‐TC concentration in cerebrospinal fluid from patients with Alzheimer disease publication-title: Clin Chem – volume: 85 start-page: 511 year: 2007 end-page: 517 article-title: Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment; results from the Sacramento Area Latino Study on Aging publication-title: Am J Clin Nutr – volume: 56 start-page: 1188 year: 2001 end-page: 1194 article-title: Vitamin B and folat in relation to the development of Alzheimer′s disease publication-title: Neurology – volume: 56 start-page: 1683 year: 2001 end-page: 1689 article-title: Midlife vascular risk factors and late‐life mild cognitive impairment: a population‐based study publication-title: Neurology – volume: 355 start-page: 523 year: 2000 end-page: 527 article-title: Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men publication-title: Lancet – volume: 33 start-page: 34 year: 2004 end-page: 41 article-title: Vitamin B12 and folate deficiency in later life publication-title: Age Ageing – volume: 50 start-page: 1025 year: 1997 end-page: 1033 article-title: Low education is a genuine risk factor for accelerated memory decline and dementia publication-title: JCE – volume: 74 start-page: 959 year: 2003 end-page: 961 article-title: Low vitamin B‐12 status in confirmed Alzheimer′s disease as revealed by serum holo‐Transcobalamin publication-title: J Neurol Neurosurg Psychiatry – volume: 11 start-page: 487 year: 1996 end-page: 496 article-title: Effects of serum vitamin B and folate status on episodic memory performance in very old age: a population based study publication-title: Psychol Aging – volume: 154 start-page: 78 year: 1993 end-page: 80 article-title: Glutamate metabotropic receptor activation in neonatal rat cerebral cortex by sulphur‐containing excitatory amino acids publication-title: Neurosci Lett – volume: 249 start-page: 423 year: 2001 end-page: 432 article-title: Serum cobalamin, folate, methylmalonic acid and total homocysteine as vitamin B and folate tissue deficiency markers amongst elderly Swedes – a population‐based study publication-title: J Intern Med – volume: 257 start-page: 289 year: 2005 end-page: 298 article-title: Holotranscobalamin – a first choice assay for diagnosing early vitamin B deficiency? publication-title: J Intern Med – volume: 354 start-page: 1578 year: 2006 end-page: 1588 article-title: Homocysteine lowering and cardiovascular events after acute myocardial infarction publication-title: N Engl J Med – volume: 36 start-page: 1739 year: 1981a end-page: 1748 article-title: Decreased transmethylation of biogenetic amines after in vivo elevation of brain S‐adenosyl‐1‐homocysteine publication-title: J Neurochem – volume: 11 start-page: 29 issue: Suppl. 1 year: 1992b end-page: 36 article-title: Occurrence of dementia in advanced age: the study design of the Kungsholmen Project publication-title: Neuroepidemiology – volume: 29 start-page: S143 year: 2008 end-page: S172 article-title: The worldwide challenge of the dementias: a role for B vitamins and homocysteine? publication-title: Food and Nutrition Bulletin – volume: 64 start-page: 86 year: 2007 end-page: 92 article-title: Relation of higher folate intake to lower risk of Alzheimer disease in the elderly publication-title: Arch Neurol |
| SSID | ssj0002720 ssib000519638 |
| Score | 2.2028153 |
| Snippet | Background: Elevated total homocysteine (tHcy) levels may be caused by vitamin B12 deficiency and are linked to Alzheimers disease (AD) in some studies,... Elevated total homocysteine (tHcy) levels may be caused by vitamin B12 deficiency and are linked to Alzheimers disease (AD) in some studies, although the... Background: Elevated total homocysteine (tHcy) levels may be caused by vitamin B12 deficiency and are linked to Alzheimers disease (AD) in some studies,... BACKGROUNDElevated total homocysteine (tHcy) levels may be caused by vitamin B12 deficiency and are linked to Alzheimers disease (AD) in some studies, although... BACKGROUND: Elevated total homocysteine (tHcy) levels may be caused by vitamin B12 deficiency and are linked to Alzheimers disease (AD) in some studies,... |
| SourceID | swepub proquest pubmed wiley istex |
| SourceType | Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 808 |
| SubjectTerms | Aged Aged, 80 and over Alzheimer Disease - epidemiology Alzheimer Disease - metabolism Alzheimers disease Community Health Planning dementia Dementia - epidemiology Dementia - metabolism Female holo-transcobalamin homocysteine Homocysteine - metabolism Humans Male Medicin och hälsovetenskap Models, Anatomic Prospective Studies Risk Assessment Risk Factors Severity of Illness Index Transcobalamins - metabolism |
| Title | Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study |
| URI | https://api.istex.fr/ark:/67375/WNG-CSDVR067-B/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1468-1331.2009.02590.x https://www.ncbi.nlm.nih.gov/pubmed/19453410 https://search.proquest.com/docview/20065186 https://search.proquest.com/docview/67537132 https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-30364 http://kipublications.ki.se/Default.aspx?queryparsed=id:118856746 |
| Volume | 16 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQHhAX3o_w9AG4pYrjxHa5laVLhbQ9AAt7s-w4hig0QW0jrfbET9jfuL-EGSftsqtyQRwqpXFeTmYy3-cZfyHkZTaWVuXOxS6THAiKdLHKjY8LJ710mVOZx_nOh3MxO8o-HOfHQ_0TzoXp9SG2A27oGeF9jQ5u7OqqkwMD4pwNspOA5JMR4knU1UN89PFCSQrTjYF75SxGM7xc1LPzQABX8U6f7MKeW2HRy5g2BKWDW6TedKevRalH3dqOitMrSo__p7-3yc0Bu9JJb2x3yLWyuUuuHw7Z-XuknrWLtkBpaPhLTeMovlrPf52tMSAWqDxiFlUTWgB3Uixrp62nLgxRViY0TH6cfi8rHE2nQ_LoDTUUeriZE0qDIu59cnQw_bw_i4ePOcQFgMIkNpZjBpJZlRVCWiuEtdwCMReWK2U9l-OEF94IJryTzGes9KlTJcrVJMLn_AHZa9qmfEQoL8C-HPfMAbtNlRt779PSS2BmuWXWROR1eHD6Zy_Yoc2yxvo1meuv8_d6_xMEfAjS-m1EXmyerAavwlSJacq2W-HHOUXOlPj7FkC0OBD8NCIPe5PYno2NsxywQRKRV72NbFtQyvtd9WWi2-U33S06jfghi0i6YzuMn3pYX1f406sS-JpSuZAZXJgIxnJx1j_JnNJoJtiLsQ5mok_0dD7Fpcf_uuMTcqPPpGGp8lOyt1525TMAZGv7PLjab-MtK90 |
| link.rule.ids | 230,315,786,790,891,1382,27955,27956,46327,46751 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hIgEX3g_z6h6AmyPb632YW2hTAjQ5QAu9rbxeL1hpbJTGUtUTP4HfyC9hZu2ktAoXxMFS7HXsbDzj-b6d2W8JeZFm0ihubWhTyYCgSBsqnruwsNJJm1qVOpzvPJmK8WH6_ogf9csB4VyYTh9iPeCGnuHf1-jgOCB92cuBAjEW97qTAOWjAQDKq-D9HL109-O5lhQmHD374nGIhnixrGfjlQCw4n99ugl9rqVFL6JaH5b2bpHjVYe6apTZoF2aQXF2SevxP_X4NrnZw1c67OztDrlS1nfJtUmfoL9HZuNm3hSoDg27NK8txbfrrx8_lxgTCxQfyedV7VsAelKsbKeNo9aPUla5bxgen30rKxxQp33-6DXNKXRxNS2UelHc--Rwb3SwMw779RzCAnBhFOaGYRIyNiothDRGCGOYAW4uDFPKOCaziBUuF7FwVsYujUuXWFWiYk0kHGcPyFbd1OUjQlkBJmaZiy0Q3ETZzDmXlE4COeMmNnlAXvknp793mh06X8ywhE1y_WX6Vu98gpgPcVq_Ccj26tFqcCzMluR12bQnuD6n4LESfz8DjIwBx08C8rCzifXd4izlAA-igLzsjGTdgmreu9XnoW4WX3U7bzVCiDQgyYbzMITq_viswk2flEDZlOJCpvDDhLeW87v-yeeURjPBXmTam4k-1aPpCD89_tcvbpPr44PJvt5_N_3whNzoEmtYufyUbC0XbfkM8NnSPPd-9xud3C_9 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLbQkCZeuMO6AfMD8JYqiR3b4a2sLeWyCgGDvVlxHENUmkxdI0174ifwG_klnOOkHZvKC-KhUhrn5uScnO_zOf5CyFOeSqMSawPLJQOCIm2gkswFuZVOWm4Vdzjf-XAqJkf8zXFy3NU_4VyYVh9iPeCGnuHf1-jgJ9ZddXJgQIxFnewkIPmwD3jyOhcsRiI2_HAhJYX5Rk--kihAO7xc1bPxSIBX8VafbQKfa2XRy6DWR6XxLTJb9actRpn1m6Xp5-dXpB7_T4dvk5sdeKWD1trukGtFdZdsH3bp-XtkNqnndY7a0PCXZpWl-G799ePnEiNijtIj2bysfAsAT4p17bR21PoxyjLzDYPv59-KEofTaZc9ekEzCj1cTQqlXhL3Pjkajz4dTILuaw5BDqgwDDLDMAUZGcVzIY0RwhhmgJkLw5Qyjsk0ZLnLRCSclZHjUeFiqwrUqwmFS9gDslXVVbFDKMvBwCxzkQV6GyubOufiwkmgZomJTNYjz_2D0yetYofOFjMsYJOJ_jJ9pQ8-QsSHKK1f9sj-6slqcCvMlWRVUTen-HVOkURK_H0LYFoMGH7cIw9bk1ifLUp5AuAg7JFnrY2sW1DLe1h-Huh68VU380YjgOA9Em_YDgOo7tbPSvzp0wIIm1KJkBwuTHhjuTjrn2xOaTQT7EWqvZnoMz2ajnBp91933Cfb74dj_e719O0eudFm1bBs-RHZWi6a4jGAs6V54r3uN-PbLqw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Homocysteine+and+holo-transcobalamin+and+the+risk+of+dementia+and+Alzheimers+disease%3A+a+prospective+study&rft.jtitle=European+journal+of+neurology&rft.au=Kivipelto%2C+M&rft.au=Annerbo%2C+S&rft.au=Hultdin%2C+J&rft.au=Backman%2C+L&rft.date=2009-07-01&rft.issn=1468-1331&rft.volume=16&rft.issue=7&rft.spage=808&rft_id=info:doi/10.1111%2Fj.1468-1331.2009.02590.x&rft.externalDocID=oai_prod_swepub_kib_ki_se_118856746 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1351-5101&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1351-5101&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1351-5101&client=summon |